Note: Ingredients listed on restricted chemical lists
EC/CAS
57-15-8
Name of the chemical
Chlorobutanol
Concentration
N/A
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
General Information
Revision date
2015-06-01
Product name
Pyridoxine Hydrochloride Injection, USP
Manufacturer Name
Fresenius Kabi USA, LLC
Icons in SDS
Company Information
company name
Fresenius Kabi USA, LLC
Section 2
SECTION 2: Hazards identification
GHS Class: Reproductive toxicity. Effects on or via lactation.
Hazard statements
May cause harm to breast-fed children.
Precautionary statements
Obtain special instructions before use. Do not breathe dust/fume/gas/mist/vapours/spray. Avoid contact during pregnancy and while nursing. Wash hands thoroughly after handling. Do not eat, drink or smoke when using this product. IF exposed or concerned: Get medical advice/attention. Emergency Overview: This product is intended for therapeutic use only when prescribed by a physician. Potential adverse reactions from prescribed doses and overdoses are described in the package insert.
Principle Routes of Exposure
Inhalation Ingestion Eye contact Skin Absorption. Injection.
Potential health effects
Eye: Contact with eyes may cause irritation. Skin: May cause skin irritation. Inhalation: May cause irritation of respiratory tract. Ingestion: May cause irritation. Signs/Symptoms: Adverse reactions from therapeutic doses include: paresthesia, somnolence, and low serum folic acid levels. Pyridoxine given to animals in amounts of 3 to 4 gm/kg of body weight, produced convulsions and death. In man, a dose of 25 mg/kg of body weight is well tolerated. Occupational exposure has not been fully investigated. Aggravation of Pre-Existing Individuals with a history of sensitivity to pyridoxine or to any of the ingredients in Pyridoxine Conditions: Hydrochloride Injection, USP.
